Stockhouse Podcasts

A ‘Barrier’ to Better Health

The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body but, in turn, ends up actively inhibiting the ability to treat disease within that sensitive region.
Bioasis Technologies Inc. (TSX-V.BTI, OTC:BIOAF, Forum) is a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. The Company’s goal is to generate shareholder value by developing and commercializing its proprietary brain delivery technology – XB3 – to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.
In this intriguing podcast, Stockhouse Media’s Dave Jackson was joined by CEO Dr. Deborah Rathjen to talk more about the Company’s amazing XB3 platform, its landmark partnership with the Chiesi Global Rare Diseases Group, and all the things Bioasis shareholders and investors should be watching for in the upcoming months.

A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

A psilocybin mushroom, also known as a magic mushroom, offers infinite medical and scientific potential…from cognitive flexibility to potentially addressing clinical depression and eating disorders. There’s a lot we still don’t know, but one Canadian company is advancing research to find out. 
Toronto ON-based Cybin Corporation is a medicinal mushroom life sciences company that views psychedelic substances derived from mushrooms as “boosters for the brain” that can potentially rebuild pathways and break negative patterns all while looking at non-psychedelic medical mushroom extracts as the next wave of nutraceuticals that can optimize overall health. 
In this fascinating podcast, Stockhouse Media’s Dave Jackson was joined by Cybin’s newly-minted CEO, Doug Drysdale, to talk about the company’s innovative research into psychedelic mental health sciences, their unique product portfolio, upcoming public listing, and much more.

Profiting from Protection: The Power of Permission-Based Partner Programs

Savvy investors know that lot of smart money is now funnelling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation.
 
Now, an innovative, Toronto-based company is making real things happen to protect consumers, companies, and capital.
 
KABN Systems (CSE.KABN, OTCMKTS: TRWRF, Forum) focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN’s propriety technology suite includes four key products – KABN ID, Liquid Avatar, KABN Card, and KABN KASH. The company provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.
 
In this extremely informative podcast, Stockhouse’s Dave Jackson was joined by KABN’s President, Co-Founder, and Director David Lucatch. Mr. Lucatch has spent more almost 35 years in the international marketing arena and over 25 years of that developing technologies and taking them to market. Prior to co-founding KABN, David held senior management posts and directorships at both private and public technology and media firms.
 
The Company believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity. 

A Major Helium Play Readies to Make its Stock Even More Valuable

One of the largest helium property holders in North America is making headlines with big news and its current market capitalization is attracting the attention of the investment community.
 
Royal Helium Ltd. (TSX-V.RHC, Forum) is focused on the exploration and development of primary helium production and has approximately 400,000 hectares of prospective helium land in south western and south-central Saskatchewan held under lease, permit or application.
 
Trading on the TSX Venture Exchange under the symbol R-H-C, the Company has been busy lately. It recently received the final analysis from the triaxial magnetic survey conducted over its Climax helium permit lands.
 
In this exclusive Stockhouse podcast, Royal Helium’s Chairman, President, and Chief Executive Officer, Andrew Davidson, took time out of his busy schedule to sit down with Stockhouse Editorial’s Dave Jackson to tell us more about where the Company, and the market, are headed.

Hire Tech. Interview with CEO Simon Dealy

Bee Vectoring Podcast

Agri-tech company Bee Vectoring Technologies International Inc. (TSX-V: BEE, OTCQB: BEVVF, Forum) has pioneered a unique and natural precision agriculture system that uses commercially-grown bees to deliver biological crop treatments to plants. BVT helps farmers drastically reduce their use of chemical pesticides, while increasing the yield of every acre of crop they grow. It’s a business that harnesses the power of nature to make the agriculture industry more sustainable, while continuing to feed the world’s growing population.
These compelling factors have helped BVT gain the attention of media across the world, farmers across the US, and investors who are building intelligent portfolios based on spotting major global trends. 
Today we’re joined by BVT’s CEO Ashish Malik and legal counsel James (question for JR – do you want to be introduced as James or Jim?) Raakman, to discuss BVT’s patent portfolio, which is an important and valuable part of the company’s growth plan.

A Potential Psychedelic and COVID Therapy Play…All in One Stock

The global concern over the ongoing coronavirus pandemic isn’t going away and even the White House’s health advisor is concerned about what protection a potential vaccine may deliver…but…could there be an answer in a drug that already exists? 
With a focus on the R-and-D of therapeutics for infectious diseases and rare disorders, specialty life sciences Company Revive Therapeutics Ltd. (CSE: RVV, OTC: RVVTF, Forum) is advancing development on what could potentially be a major windfall as the world continues to grapple with the COVID-19 coronavirus pandemic. 
The Company is taking advantage of several F-D-A incentives to explore the use of Bucillamine (boo-SILL-ih-mine) for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19. Revive Therapeutics also just made news when it filed its Clinical Trial Application with Health Canada. 
Stockhouse Editorial’s Dave Jackson was joined by Revive Therapeutics CEO Michael Frank and Derrick Welsh, Founder and C-O-O of Psilocin Pharma Corp, to talk more about what amazing possibilities Bucillamine could offer, future investment opportunities in the exploding magic / mushroom / psilocybin space, and to learn more about their companies in general.

The ‘Lean Mean Fighting Machine’ That’s Redefining the Cannabis 2.0 Marketplace

The rubber has finally hit the road for Cannabis 2.0. And conventional wisdom says the infused beverage market to be the engine that will drive it. 
Hill Street Beverage Company Inc. (TSX-V.BEER, OTCQB: HSEEF, Forum) boasts some of the infused beverage sector’s most innovative and bold marketing initiatives to capture a huge new audience that’s looking for healthier alternatives to alcohol. This rapidly growing market that has the potential to disrupt the trillion-dollar alcohol industry. 
Hill Street are producers of the “world’s first alcohol-free premium craft beer”. The Company has won numerous international awards for its alcohol-free beer and wine. They have been at the forefront of a campaign to raise awareness of the health risks associated with alcohol consumption. Having focused on producing world-class alcohol-free beer and wine since the Company’s inception in 2008 gives the Company a huge jumpstart over the big booze partnerships with cannabis companies. Thus, its decade-plus head start on positioning itself in this market and in developing market penetration strategies makes Hill Street truly unique to this space. The Company trades on the TSX Venture Exchange under the symbol, appropriately, BEER.
In this informative and entertaining podcast, Stockhouse Media's Dave Jackson was joined by Hill Street Beverage’s Chairman & CEO Terry Donnelly to learn more about the Company’s remarkable financial results despite the COVID-19 pandemic, its proprietary technology that’s truly a game-changer in the sector, and a wide variety of timely and newsworthy topics moving forward through 2020.